Creating the first genetically susceptible mice for late-onset Alzheimer’s
Mice don’t get Alzheimer’s-;and while that’s good news for mice, it’s a big problem for biomedical researchers seeking to understand the disease and test new
Mice don’t get Alzheimer’s-;and while that’s good news for mice, it’s a big problem for biomedical researchers seeking to understand the disease and test new
Mark Petersen, MD, has seen firsthand the devastating effects of brain bleeds in premature babies. It’s an exceedingly common condition that affects up to 20
Ductal carcinoma in situ (DCIS) is a type of preinvasive tumor that sometimes progresses to a highly deadly form of breast cancer. It accounts for
Viking Therapeutics plans to move its injectable obesity treatment into a Phase 3 study faster than expected, bringing the biotech closer to joining the highly
Review highlights kaempferol’s potential in treating triple-negative breast cancer through various anticancer mechanisms and improving chemotherapeutic efficacy.
A recent study found that lifestyle and socioeconomic factors influence the negative impact of ultra-processed foods (UPF) on health-related quality of life (HRQoL). Higher UPF
Researchers have developed sparse prediction models combining plasma proteins and clinical data to predict the 10-year risk of 218 diseases. The study, involving over 41,000
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced the export of nature-derived psilocybin to Australia and provided an update
What You Should Know: – Linus Health, a leader in early detection of cognitive decline and dementia, announced today the acquisition of Together Senior Health.
By the numbers Q2 sales: $4.12 billion 14.5% year-over-year growth Cardiovascular sales: $2.64 bilion 17.8% year-over-year growth Electrophysiology sales: $428 million Nearly 122% year-over-year growth